Thomas G. Wiggans
Director, Onyx Pharmaceuticals.
Companies
- Pacira BioSciences, Inc.Board member Jun 12, 2026 to now1
- Jasper Therapeutics, Inc.Board member Nov 2, 2023 to now2
- Annexon, Inc.Board member Jul 23, 2020 to now3
- CymaBay Therapeutics (United States)Board member Apr 5, 2021 to Mar 22, 20244
- PARDES BIOSCIENCES, INC.Board member Mar 4, 2022 to Aug 31, 20235
- PARDES BIOSCIENCES, INC.Chief executive officer Mar 4, 2022 to Aug 31, 20235
- Forma Therapeutics Holdings, Inc.Board member Sep 9, 2020 to Oct 14, 20226
- Dermira (United States)Chief executive officer Oct 2, 2014 to Feb 24, 20207
- Dermira (United States)Chair Oct 2, 2014 to Feb 24, 20207
- Onyx PharmaceuticalsBoard member Mar 10, 2006 to Oct 3, 20138
- SANGAMO THERAPEUTICS, INCBoard member Jun 6, 2008 to Jun 3, 20119
- TercicaBoard member Feb 14, 2006 to Jun 16, 200610
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jasper Therapeutics, Inc. JSPR46,000 shares11$24.5K at $0.53Sep 24, 2025
- Forma Therapeutics Holdings, Inc.0 shares12Oct 14, 2022
- PARDES BIOSCIENCES, INC.0 shares13Aug 31, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 22, 2025Bought 41,000 shares at $2.43 of Jasper Therapeutics, Inc.11
- Nov 28, 2023Bought 10,000 shares at $0.65 of Jasper Therapeutics, Inc.14
- Nov 21, 2023Bought 10,000 shares at $0.64 of Jasper Therapeutics, Inc.15
- Nov 20, 2023Bought 10,000 shares at $0.63 of Jasper Therapeutics, Inc.16
- Nov 17, 2023Bought 10,000 shares at $0.60 of Jasper Therapeutics, Inc.16
- Nov 16, 2023Bought 10,000 shares at $0.60 of Jasper Therapeutics, Inc.16
- Aug 31, 2023U 50,000 shares of PARDES BIOSCIENCES, INC.13
- Dec 5, 2022Bought 12,500 shares at $1.09 of PARDES BIOSCIENCES, INC.17
- Dec 2, 2022Bought 12,500 shares at $1.07 of PARDES BIOSCIENCES, INC.18
- Dec 1, 2022Bought 25,000 shares at $1.04 of PARDES BIOSCIENCES, INC.18
- Oct 14, 2022U 7,250 shares of Forma Therapeutics Holdings, Inc.12
- Jun 8, 2022Granted 4,500 shares of Forma Therapeutics Holdings, Inc.19
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARAnnexon, Inc., Board member
- 4
- 5
- 6
- 7
- 8SEC EDGAROnyx Pharmaceuticals, Board member
- 9
- 10SEC EDGARTercica, Board member
- 11
- 12
- 13
- 14SEC EDGARForm 4 filed Nov 30, 2023
- 15SEC EDGARForm 4 filed Nov 22, 2023
- 16SEC EDGARForm 4 filed Nov 20, 2023
- 17SEC EDGARForm 4 filed Dec 7, 2022
- 18SEC EDGARForm 4 filed Dec 5, 2022
- 19SEC EDGARForm 4 filed Jun 9, 2022